nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—ALB—chronic obstructive pulmonary disease	0.369	1	CbGaD
Irinotecan—ALB—Prednisone—chronic obstructive pulmonary disease	0.0358	0.179	CbGbCtD
Irinotecan—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0353	0.177	CbGbCtD
Irinotecan—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0238	0.119	CbGbCtD
Irinotecan—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0227	0.114	CbGbCtD
Irinotecan—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0203	0.102	CbGbCtD
Irinotecan—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0199	0.0994	CbGbCtD
Irinotecan—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0187	0.0939	CbGbCtD
Irinotecan—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0119	0.0596	CbGbCtD
Irinotecan—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0112	0.0562	CbGbCtD
Irinotecan—BCHE—diaphragm—chronic obstructive pulmonary disease	0.0109	0.163	CbGeAlD
Irinotecan—TOP1MT—respiratory system—chronic obstructive pulmonary disease	0.00642	0.0963	CbGeAlD
Irinotecan—TOP1MT—lung—chronic obstructive pulmonary disease	0.00341	0.0511	CbGeAlD
Irinotecan—CES2—respiratory system—chronic obstructive pulmonary disease	0.00307	0.0461	CbGeAlD
Irinotecan—TOP1—bronchus—chronic obstructive pulmonary disease	0.00279	0.0418	CbGeAlD
Irinotecan—TOP1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00273	0.0409	CbGeAlD
Irinotecan—CES1—respiratory system—chronic obstructive pulmonary disease	0.00253	0.0379	CbGeAlD
Irinotecan—CES2—bronchus—chronic obstructive pulmonary disease	0.00253	0.0379	CbGeAlD
Irinotecan—TOP1—trachea—chronic obstructive pulmonary disease	0.0025	0.0375	CbGeAlD
Irinotecan—CES2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00247	0.0371	CbGeAlD
Irinotecan—CES2—trachea—chronic obstructive pulmonary disease	0.00227	0.034	CbGeAlD
Irinotecan—CES1—connective tissue—chronic obstructive pulmonary disease	0.00223	0.0334	CbGeAlD
Irinotecan—TOP1—lung—chronic obstructive pulmonary disease	0.0018	0.027	CbGeAlD
Irinotecan—CES2—lung—chronic obstructive pulmonary disease	0.00163	0.0245	CbGeAlD
Irinotecan—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.00154	0.0232	CbGeAlD
Irinotecan—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00141	0.0212	CbGeAlD
Irinotecan—CES1—lung—chronic obstructive pulmonary disease	0.00134	0.0201	CbGeAlD
Irinotecan—BCHE—respiratory system—chronic obstructive pulmonary disease	0.00124	0.0186	CbGeAlD
Irinotecan—ABCC1—bronchus—chronic obstructive pulmonary disease	0.00119	0.0179	CbGeAlD
Irinotecan—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00111	0.0167	CbGeAlD
Irinotecan—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.00111	0.0166	CbGeAlD
Irinotecan—ABCC1—trachea—chronic obstructive pulmonary disease	0.00107	0.0161	CbGeAlD
Irinotecan—BCHE—bronchus—chronic obstructive pulmonary disease	0.00102	0.0153	CbGeAlD
Irinotecan—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.001	0.015	CbGeAlD
Irinotecan—SLC22A3—lung—chronic obstructive pulmonary disease	0.000932	0.014	CbGeAlD
Irinotecan—BCHE—trachea—chronic obstructive pulmonary disease	0.000918	0.0138	CbGeAlD
Irinotecan—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000912	0.0137	CbGeAlD
Irinotecan—ABCC1—lung—chronic obstructive pulmonary disease	0.00077	0.0116	CbGeAlD
Irinotecan—BCHE—lung—chronic obstructive pulmonary disease	0.00066	0.0099	CbGeAlD
Irinotecan—ABCG2—lung—chronic obstructive pulmonary disease	0.000638	0.00957	CbGeAlD
Irinotecan—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000592	0.00888	CbGeAlD
Irinotecan—CYP3A5—lung—chronic obstructive pulmonary disease	0.000592	0.00888	CbGeAlD
Irinotecan—CYP2B6—lung—chronic obstructive pulmonary disease	0.000588	0.00883	CbGeAlD
Irinotecan—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000539	0.0022	CcSEcCtD
Irinotecan—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000536	0.00219	CcSEcCtD
Irinotecan—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000534	0.00219	CcSEcCtD
Irinotecan—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000529	0.00217	CcSEcCtD
Irinotecan—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000528	0.00216	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000527	0.00216	CcSEcCtD
Irinotecan—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000527	0.00216	CcSEcCtD
Irinotecan—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000527	0.00216	CcSEcCtD
Irinotecan—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000519	0.00212	CcSEcCtD
Irinotecan—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000518	0.00212	CcSEcCtD
Irinotecan—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00211	CcSEcCtD
Irinotecan—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000515	0.00211	CcSEcCtD
Irinotecan—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00209	CcSEcCtD
Irinotecan—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00209	CcSEcCtD
Irinotecan—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000511	0.00209	CcSEcCtD
Irinotecan—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.00051	0.00209	CcSEcCtD
Irinotecan—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000505	0.00207	CcSEcCtD
Irinotecan—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000498	0.00204	CcSEcCtD
Irinotecan—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000497	0.00203	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000495	0.00203	CcSEcCtD
Irinotecan—Cough—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00203	CcSEcCtD
Irinotecan—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00203	CcSEcCtD
Irinotecan—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000491	0.00201	CcSEcCtD
Irinotecan—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00049	0.00201	CcSEcCtD
Irinotecan—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00049	0.00201	CcSEcCtD
Irinotecan—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000485	0.00199	CcSEcCtD
Irinotecan—Cough—Montelukast—chronic obstructive pulmonary disease	0.000485	0.00199	CcSEcCtD
Irinotecan—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00198	CcSEcCtD
Irinotecan—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00197	CcSEcCtD
Irinotecan—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000481	0.00197	CcSEcCtD
Irinotecan—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000481	0.00197	CcSEcCtD
Irinotecan—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00197	CcSEcCtD
Irinotecan—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00195	CcSEcCtD
Irinotecan—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00195	CcSEcCtD
Irinotecan—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.00193	CcSEcCtD
Irinotecan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000469	0.00192	CcSEcCtD
Irinotecan—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00191	CcSEcCtD
Irinotecan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.0019	CcSEcCtD
Irinotecan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000463	0.0019	CcSEcCtD
Irinotecan—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000463	0.0019	CcSEcCtD
Irinotecan—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.0019	CcSEcCtD
Irinotecan—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000463	0.00189	CcSEcCtD
Irinotecan—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00188	CcSEcCtD
Irinotecan—Infection—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00188	CcSEcCtD
Irinotecan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00186	CcSEcCtD
Irinotecan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00186	CcSEcCtD
Irinotecan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000454	0.00186	CcSEcCtD
Irinotecan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000454	0.00186	CcSEcCtD
Irinotecan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000454	0.00186	CcSEcCtD
Irinotecan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000451	0.00184	CcSEcCtD
Irinotecan—Infection—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00184	CcSEcCtD
Irinotecan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000448	0.00184	CcSEcCtD
Irinotecan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000445	0.00182	CcSEcCtD
Irinotecan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000444	0.00182	CcSEcCtD
Irinotecan—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000444	0.00182	CcSEcCtD
Irinotecan—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000443	0.00181	CcSEcCtD
Irinotecan—ABCB1—trachea—chronic obstructive pulmonary disease	0.000438	0.00657	CbGeAlD
Irinotecan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00179	CcSEcCtD
Irinotecan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00179	CcSEcCtD
Irinotecan—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000434	0.00178	CcSEcCtD
Irinotecan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000433	0.00177	CcSEcCtD
Irinotecan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.00177	CcSEcCtD
Irinotecan—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000432	0.00177	CcSEcCtD
Irinotecan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.00176	CcSEcCtD
Irinotecan—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00043	0.00176	CcSEcCtD
Irinotecan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00176	CcSEcCtD
Irinotecan—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000428	0.00175	CcSEcCtD
Irinotecan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000423	0.00173	CcSEcCtD
Irinotecan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00173	CcSEcCtD
Irinotecan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00171	CcSEcCtD
Irinotecan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00171	CcSEcCtD
Irinotecan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00171	CcSEcCtD
Irinotecan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000416	0.0017	CcSEcCtD
Irinotecan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00169	CcSEcCtD
Irinotecan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00169	CcSEcCtD
Irinotecan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000412	0.00169	CcSEcCtD
Irinotecan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000412	0.00169	CcSEcCtD
Irinotecan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00168	CcSEcCtD
Irinotecan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00167	CcSEcCtD
Irinotecan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.00167	CcSEcCtD
Irinotecan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000408	0.00167	CcSEcCtD
Irinotecan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00167	CcSEcCtD
Irinotecan—Injury—Prednisone—chronic obstructive pulmonary disease	0.000403	0.00165	CcSEcCtD
Irinotecan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000403	0.00165	CcSEcCtD
Irinotecan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00165	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00164	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00164	CcSEcCtD
Irinotecan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000399	0.00163	CcSEcCtD
Irinotecan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00163	CcSEcCtD
Irinotecan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00163	CcSEcCtD
Irinotecan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00162	CcSEcCtD
Irinotecan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00162	CcSEcCtD
Irinotecan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00162	CcSEcCtD
Irinotecan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00162	CcSEcCtD
Irinotecan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00162	CcSEcCtD
Irinotecan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00161	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000392	0.0016	CcSEcCtD
Irinotecan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000391	0.0016	CcSEcCtD
Irinotecan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.0016	CcSEcCtD
Irinotecan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000389	0.00159	CcSEcCtD
Irinotecan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000388	0.00159	CcSEcCtD
Irinotecan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000388	0.00159	CcSEcCtD
Irinotecan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000387	0.00158	CcSEcCtD
Irinotecan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000385	0.00158	CcSEcCtD
Irinotecan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00158	CcSEcCtD
Irinotecan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000384	0.00157	CcSEcCtD
Irinotecan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000383	0.00157	CcSEcCtD
Irinotecan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00156	CcSEcCtD
Irinotecan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00156	CcSEcCtD
Irinotecan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000381	0.00156	CcSEcCtD
Irinotecan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00156	CcSEcCtD
Irinotecan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00155	CcSEcCtD
Irinotecan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00155	CcSEcCtD
Irinotecan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00155	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00155	CcSEcCtD
Irinotecan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00154	CcSEcCtD
Irinotecan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00153	CcSEcCtD
Irinotecan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00153	CcSEcCtD
Irinotecan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000371	0.00152	CcSEcCtD
Irinotecan—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000371	0.00152	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000371	0.00152	CcSEcCtD
Irinotecan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.0015	CcSEcCtD
Irinotecan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.0015	CcSEcCtD
Irinotecan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000366	0.0015	CcSEcCtD
Irinotecan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000366	0.0015	CcSEcCtD
Irinotecan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000365	0.00149	CcSEcCtD
Irinotecan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000362	0.00148	CcSEcCtD
Irinotecan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000361	0.00148	CcSEcCtD
Irinotecan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000361	0.00148	CcSEcCtD
Irinotecan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00147	CcSEcCtD
Irinotecan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00036	0.00147	CcSEcCtD
Irinotecan—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.00147	CcSEcCtD
Irinotecan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00147	CcSEcCtD
Irinotecan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00147	CcSEcCtD
Irinotecan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00146	CcSEcCtD
Irinotecan—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.00145	CcSEcCtD
Irinotecan—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000353	0.00145	CcSEcCtD
Irinotecan—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000353	0.00144	CcSEcCtD
Irinotecan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00141	CcSEcCtD
Irinotecan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00141	CcSEcCtD
Irinotecan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000341	0.0014	CcSEcCtD
Irinotecan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.0014	CcSEcCtD
Irinotecan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000341	0.0014	CcSEcCtD
Irinotecan—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00034	0.00139	CcSEcCtD
Irinotecan—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00138	CcSEcCtD
Irinotecan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00137	CcSEcCtD
Irinotecan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000332	0.00136	CcSEcCtD
Irinotecan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000332	0.00136	CcSEcCtD
Irinotecan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000325	0.00133	CcSEcCtD
Irinotecan—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000323	0.00132	CcSEcCtD
Irinotecan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00132	CcSEcCtD
Irinotecan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000317	0.0013	CcSEcCtD
Irinotecan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.0013	CcSEcCtD
Irinotecan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000315	0.00129	CcSEcCtD
Irinotecan—ABCB1—lung—chronic obstructive pulmonary disease	0.000314	0.00472	CbGeAlD
Irinotecan—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000314	0.00129	CcSEcCtD
Irinotecan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00128	CcSEcCtD
Irinotecan—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000312	0.00128	CcSEcCtD
Irinotecan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00031	0.00127	CcSEcCtD
Irinotecan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00125	CcSEcCtD
Irinotecan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00125	CcSEcCtD
Irinotecan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00123	CcSEcCtD
Irinotecan—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.0003	0.00123	CcSEcCtD
Irinotecan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00122	CcSEcCtD
Irinotecan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00121	CcSEcCtD
Irinotecan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00121	CcSEcCtD
Irinotecan—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.0012	CcSEcCtD
Irinotecan—Rash—Formoterol—chronic obstructive pulmonary disease	0.000292	0.0012	CcSEcCtD
Irinotecan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00119	CcSEcCtD
Irinotecan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00119	CcSEcCtD
Irinotecan—Headache—Formoterol—chronic obstructive pulmonary disease	0.00029	0.00119	CcSEcCtD
Irinotecan—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00029	0.00119	CcSEcCtD
Irinotecan—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00119	CcSEcCtD
Irinotecan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00118	CcSEcCtD
Irinotecan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00118	CcSEcCtD
Irinotecan—Rash—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00117	CcSEcCtD
Irinotecan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00117	CcSEcCtD
Irinotecan—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.00117	CcSEcCtD
Irinotecan—Headache—Montelukast—chronic obstructive pulmonary disease	0.000284	0.00116	CcSEcCtD
Irinotecan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000282	0.00115	CcSEcCtD
Irinotecan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00115	CcSEcCtD
Irinotecan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00114	CcSEcCtD
Irinotecan—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.00113	CcSEcCtD
Irinotecan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00113	CcSEcCtD
Irinotecan—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00113	CcSEcCtD
Irinotecan—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00113	CcSEcCtD
Irinotecan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00113	CcSEcCtD
Irinotecan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000275	0.00113	CcSEcCtD
Irinotecan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00113	CcSEcCtD
Irinotecan—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00112	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00027	0.00111	CcSEcCtD
Irinotecan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000269	0.0011	CcSEcCtD
Irinotecan—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.00109	CcSEcCtD
Irinotecan—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00107	CcSEcCtD
Irinotecan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00106	CcSEcCtD
Irinotecan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00106	CcSEcCtD
Irinotecan—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000258	0.00106	CcSEcCtD
Irinotecan—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00105	CcSEcCtD
Irinotecan—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00103	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00103	CcSEcCtD
Irinotecan—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00103	CcSEcCtD
Irinotecan—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000247	0.00101	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000242	0.000992	CcSEcCtD
Irinotecan—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000975	CcSEcCtD
Irinotecan—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000953	CcSEcCtD
Irinotecan—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000948	CcSEcCtD
Irinotecan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000938	CcSEcCtD
Irinotecan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.000929	CcSEcCtD
Irinotecan—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000928	CcSEcCtD
Irinotecan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000922	CcSEcCtD
Irinotecan—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000878	CcSEcCtD
Irinotecan—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000848	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000846	CcSEcCtD
Irinotecan—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000845	CcSEcCtD
Irinotecan—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000824	CcSEcCtD
Irinotecan—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000821	CcSEcCtD
Irinotecan—Syncope—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00082	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000803	CcSEcCtD
Irinotecan—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000789	CcSEcCtD
Irinotecan—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000769	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.000756	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000746	CcSEcCtD
Irinotecan—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000746	CcSEcCtD
Irinotecan—Infection—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000741	CcSEcCtD
Irinotecan—Shock—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000734	CcSEcCtD
Irinotecan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000732	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000721	CcSEcCtD
Irinotecan—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000711	CcSEcCtD
Irinotecan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000679	CcSEcCtD
Irinotecan—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000675	CcSEcCtD
Irinotecan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00067	CcSEcCtD
Irinotecan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000657	CcSEcCtD
Irinotecan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000649	CcSEcCtD
Irinotecan—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000647	CcSEcCtD
Irinotecan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000647	CcSEcCtD
Irinotecan—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000643	CcSEcCtD
Irinotecan—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000643	CcSEcCtD
Irinotecan—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000638	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000615	CcSEcCtD
Irinotecan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00061	CcSEcCtD
Irinotecan—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00061	CcSEcCtD
Irinotecan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00059	CcSEcCtD
Irinotecan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00059	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00055	CcSEcCtD
Irinotecan—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000535	CcSEcCtD
Irinotecan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00051	CcSEcCtD
Irinotecan—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000493	CcSEcCtD
Irinotecan—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000474	CcSEcCtD
Irinotecan—Rash—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00047	CcSEcCtD
Irinotecan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00047	CcSEcCtD
Irinotecan—Headache—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000467	CcSEcCtD
Irinotecan—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000443	CcSEcCtD
Irinotecan—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	6.3e-05	0.000523	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.29e-05	0.000522	CbGpPWpGaD
Irinotecan—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.28e-05	0.000522	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.2e-05	0.000515	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	6.17e-05	0.000513	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	6.16e-05	0.000512	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	6.12e-05	0.000508	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	6.12e-05	0.000508	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	6.05e-05	0.000502	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	5.91e-05	0.000491	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	5.85e-05	0.000486	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	5.83e-05	0.000484	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.74e-05	0.000477	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.73e-05	0.000476	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.69e-05	0.000472	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.68e-05	0.000472	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.66e-05	0.00047	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	5.62e-05	0.000467	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	5.6e-05	0.000465	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.59e-05	0.000465	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	5.55e-05	0.000461	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	5.55e-05	0.000461	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	5.49e-05	0.000456	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	5.46e-05	0.000453	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.46e-05	0.000453	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.39e-05	0.000448	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.38e-05	0.000447	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.32e-05	0.000442	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.32e-05	0.000441	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GCLC—chronic obstructive pulmonary disease	5.26e-05	0.000437	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.2e-05	0.000432	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	5.18e-05	0.00043	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	5.16e-05	0.000428	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	5.12e-05	0.000425	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.07e-05	0.000421	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.04e-05	0.000419	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.94e-05	0.00041	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.92e-05	0.000409	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.82e-05	0.0004	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.81e-05	0.0004	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.81e-05	0.000399	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CTGF—chronic obstructive pulmonary disease	4.8e-05	0.000399	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.66e-05	0.000387	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.65e-05	0.000386	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.55e-05	0.000378	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.55e-05	0.000378	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	4.53e-05	0.000376	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.49e-05	0.000373	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	4.42e-05	0.000367	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.42e-05	0.000367	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	4.4e-05	0.000366	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	4.31e-05	0.000358	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	4.26e-05	0.000354	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.21e-05	0.00035	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.21e-05	0.000349	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.19e-05	0.000348	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.18e-05	0.000347	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	4.14e-05	0.000344	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.13e-05	0.000343	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.11e-05	0.000341	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	4.09e-05	0.00034	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.07e-05	0.000338	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.97e-05	0.00033	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.97e-05	0.00033	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.97e-05	0.000329	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.93e-05	0.000326	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.93e-05	0.000326	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	3.93e-05	0.000326	CbGpPWpGaD
Irinotecan—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.92e-05	0.000325	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.91e-05	0.000325	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.89e-05	0.000323	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.88e-05	0.000322	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.86e-05	0.000321	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	3.85e-05	0.000319	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.83e-05	0.000318	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.81e-05	0.000316	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	3.8e-05	0.000316	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.79e-05	0.000315	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	3.78e-05	0.000314	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.74e-05	0.00031	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	3.69e-05	0.000307	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.69e-05	0.000306	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.66e-05	0.000304	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.64e-05	0.000302	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.64e-05	0.000302	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.6e-05	0.000299	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.59e-05	0.000298	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.59e-05	0.000298	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KL—chronic obstructive pulmonary disease	3.58e-05	0.000297	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.54e-05	0.000294	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.53e-05	0.000293	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.48e-05	0.000289	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.46e-05	0.000287	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.44e-05	0.000286	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.43e-05	0.000285	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.4e-05	0.000282	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.39e-05	0.000281	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.37e-05	0.00028	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	3.37e-05	0.00028	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.36e-05	0.000279	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.36e-05	0.000279	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.34e-05	0.000278	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.34e-05	0.000277	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.33e-05	0.000277	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	3.3e-05	0.000274	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.3e-05	0.000274	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.3e-05	0.000274	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.29e-05	0.000273	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.21e-05	0.000267	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.19e-05	0.000265	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.19e-05	0.000265	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.19e-05	0.000265	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.11e-05	0.000258	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.1e-05	0.000258	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.04e-05	0.000253	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.04e-05	0.000252	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.03e-05	0.000251	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.02e-05	0.00025	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.96e-05	0.000245	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.9e-05	0.000241	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.86e-05	0.000238	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.83e-05	0.000235	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.82e-05	0.000234	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.82e-05	0.000234	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.8e-05	0.000233	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.78e-05	0.000231	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.78e-05	0.000231	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.77e-05	0.00023	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.75e-05	0.000229	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.75e-05	0.000229	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.73e-05	0.000227	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.72e-05	0.000226	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.72e-05	0.000226	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	2.68e-05	0.000223	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.67e-05	0.000222	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.66e-05	0.000221	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.66e-05	0.000221	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.62e-05	0.000218	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.59e-05	0.000215	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.59e-05	0.000215	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.55e-05	0.000212	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.55e-05	0.000211	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.53e-05	0.00021	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.53e-05	0.00021	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.53e-05	0.00021	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	2.53e-05	0.00021	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.52e-05	0.00021	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.51e-05	0.000208	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.5e-05	0.000207	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.49e-05	0.000207	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.47e-05	0.000205	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.44e-05	0.000203	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.44e-05	0.000203	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.42e-05	0.000201	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.4e-05	0.000199	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.4e-05	0.000199	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.39e-05	0.000198	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.38e-05	0.000198	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.38e-05	0.000197	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.34e-05	0.000194	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.000193	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.32e-05	0.000192	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000192	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.31e-05	0.000191	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.29e-05	0.00019	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.26e-05	0.000187	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	2.23e-05	0.000186	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.23e-05	0.000185	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000183	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	2.18e-05	0.000181	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.18e-05	0.000181	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.15e-05	0.000178	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.13e-05	0.000177	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.11e-05	0.000176	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.11e-05	0.000175	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.1e-05	0.000174	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	2.09e-05	0.000174	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.08e-05	0.000173	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	2.06e-05	0.000171	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.06e-05	0.000171	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.05e-05	0.000171	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.04e-05	0.000169	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.000168	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.02e-05	0.000167	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.01e-05	0.000167	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.91e-05	0.000159	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.88e-05	0.000156	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.88e-05	0.000156	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.82e-05	0.000151	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.8e-05	0.00015	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.8e-05	0.000149	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.73e-05	0.000144	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	1.72e-05	0.000143	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.71e-05	0.000142	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.69e-05	0.00014	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.67e-05	0.000139	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.65e-05	0.000137	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.64e-05	0.000137	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.64e-05	0.000137	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.63e-05	0.000135	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	1.63e-05	0.000135	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000133	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.57e-05	0.000131	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	1.57e-05	0.000131	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.56e-05	0.00013	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.56e-05	0.00013	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.54e-05	0.000128	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	1.53e-05	0.000127	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.52e-05	0.000126	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.5e-05	0.000125	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.49e-05	0.000124	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.000124	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	1.47e-05	0.000122	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.46e-05	0.000121	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.45e-05	0.000121	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.44e-05	0.00012	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.43e-05	0.000119	CbGpPWpGaD
Irinotecan—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.42e-05	0.000118	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.38e-05	0.000115	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000114	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.33e-05	0.000111	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.33e-05	0.00011	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.00011	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000109	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000105	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.000104	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.000104	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	1.19e-05	9.87e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	1.16e-05	9.67e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	9.64e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	9.33e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	9.22e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	9.14e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.1e-05	9.11e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.01e-05	8.43e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	8.41e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	9.92e-06	8.24e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	9.71e-06	8.06e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	9.49e-06	7.88e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.34e-06	7.75e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	8.95e-06	7.43e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	8.17e-06	6.79e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.79e-06	6.47e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.68e-06	6.38e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	7.48e-06	6.22e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.16e-06	5.94e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.16e-06	5.94e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.78e-06	5.63e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.61e-06	3.83e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.41e-06	3.66e-05	CbGpPWpGaD
